Analyst Target Price & Stock Review on Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) – Hermann Herald

This post was originally published on this site

Analyst Target Price & Stock Review on Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)  Hermann Herald

Wall Street brokerage firm analysts have placed a “Buy” rating on shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS). Using the following ratings.

This post was originally published on *this site*